My Locations
About Me
I specialize in the treatment of gastrointestinal (GI) cancers with a focus on clinical trials. Clinical trial patients can come to me at any point during their disease, but they usually come to me looking for an alternative therapy once standard treatments have not been effective. I decided to become a doctor later in my career. I originally graduated from university with a non-science degree, but the excitement of advancing medical breakthroughs inspired me to start a career in medicine. As a Duke physician, I enjoy the diverse experiences that I get to have each week. In addition to taking care of patients and conducting research, I work closely with other doctors on crafting treatment plans. I also find it fulfilling to be able to apply my research to patient care. In my spare time, I enjoy spending time with my family, jogging and skiing.
Areas of Expertise
Ratings and Reviews
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
Clinical Focus and Research
My research focuses on new therapies for cancer and non-invasive tests to determine which therapy will help patients best. It is my hope that these technologies will deliver meaningful benefit to patients, reduce side effects and transform the future of cancer care.
-
AMG 510 in Advanced Solid Tumors With KRAS p.G12C MutationIRB# PRO00104161 , NCT# NCT04185883
-
MOUNTAINEER-03 (Colorectal Cancer)IRB# PRO00110153 , NCT# NCT05253651
-
ABBV-400 for Advanced Solid TumorsIRB# PRO00111582 , NCT# NCT05029882
-
ABBV-400 in Select Advanced Solid Tumor IndicationsIRB# PRO00113960 , NCT# NCT06084481
-
LBL-007+ Tislelizumab w/Bevacizumab vs. Bevacizumab and capecitabine in CRC (Colorectal Cancer)IRB# PRO00112102 , NCT# NCT05609370
-
Dabrafenib + Trametinib in Patients w/rare BRAF V600E Mutated Solid Tumor (CDRB436IIC01)IRB# PRO00113811 , NCT# NCT05868629
-
Study drug RO7589831 for MSI/dMMR solid tumors (BP44474)IRB# PRO00113812 , NCT# NCT06004245
-
Study drug QTX3034 for patients with KRAS G12D solid tumors (QTX3034-001)IRB# PRO00114908 , NCT# NCT06227377
-
BGB-3245+Panitumumab in Advanced/Metastatic RAS mutant CRC & Pancreatic Ductal Cancers (MapKure)IRB# PRO00114943 , NCT# NCT06194877
-
Perioperative dostarlimab vs standard of care for resectable colon cancer (219606) (AZUR)IRB# PRO00113870 , NCT# NCT05855200
-
Amgen2021: Advanced Solid Tumors with KRAS p.G12C MutationIRB# PRO00114638 , NCT# NCT06252649
-
APL-5125 (Gastrointestinal Cancers)IRB# PRO00115529 , NCT# NCT06399757
-
EAY191 (ComboMATCH)IRB# PRO00113715 , NCT# NCT05564377
-
Study drug RMC-9805 for patients with KRAS G12D solid tumors (RMC-9805-001)IRB# PRO00114818 , NCT# NCT06040541
-
RMC-6236 (Unresectable or Metastatic Colorectal Cancer or Pancreatic Cancer)IRB# PRO00115657 , NCT# NCT06445062
-
RMC-6236 + cetuximab for colorectal or pancreatic cancer (RMC-GI-102_B)IRB# PRO00115669 , NCT# NCT06445062
-
RMC-6236 + gemcitabine and nab-paclitaxel for pancreatic cancer (RMC-GI-102_C)IRB# PRO00115670 , NCT# NCT06445062
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- AbbVie, Inc.
- Amgen, Inc.
- Astellas Pharma Inc.
- AstraZeneca
- Bayer
- BeiGene
- Bristol-Myers Squibb (BMS)
- Daiichi Sankyo Co., Ltd
- Eli Lilly & Co.
- GE Healthcare
- Genentech, Inc (Roche Holding)
- GlaxoSmithKline
- Incyte
- Ipsen
- Jazz Pharmaceuticals
- Johnson and Johnson
- Merck Sharp & Dohme Inc., One Merck Drive, Whitehouse Station, NJ 08889-0100.
- Natera
- Pfizer Inc.
- Quanta Therapeutics
- Regeneron Pharmaceuticals
- Sanofi
- Taiho
- Takeda Oncology
- Triumvira Immunologics
- Xilio Therapeutics
- Xilio Therapeutics